BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 2:59:00 PM | Browse: 1538 | Download: 1433
 |
Received |
|
2013-06-30 10:21 |
 |
Peer-Review Started |
|
2013-07-01 17:26 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-07-22 16:58 |
 |
Revised |
|
2013-08-06 13:30 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-08-13 11:57 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-08-13 14:00 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-10-23 19:03 |
 |
Publish the Manuscript Online |
|
2013-11-29 02:07 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Probiotics in inflammatory bowel disease: Pathophysiological background and clinical applications
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Cristiano Pagnini, Gianfranco Delle Fave and Giorgos Bamias |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Giorgos Bamias, MD, Consultant in Gastroenterology, Academic Department of Gastroenterology, Laikon Hospital, Ethnikon and Kapodistriakon University, 17 Agiou Thoma Street, Athens 11527, Greece. gbamias@gmail.com |
| Key Words |
Probiotics; Commensal flora; Mucosa-associated immune system; Inflammatory bowel disease; Clinical trials; Pouchitis; Ulcerative colitis; Crohn’s disease |
| Core Tip |
Inflammatory bowel diseases are chronic debilitating diseases of the gastrointestinal tract. Current therapies are not effective in a great proportion of patients and are associated with serious adverse effects. The use of probiotics has been tried as an alternative and safe treatment. Herein, we review the pathophysiological basis for such an application and summarize the data from the major clinical trials. |
| Publish Date |
2013-11-29 02:07 |
| Citation |
Pagnini C, Delle Fave G, Bamias G. Probiotics in inflammatory bowel disease: Pathophysiological background and clinical applications. World J Immunol 2013; 3(3): 31-43 |
| URL |
http://www.wjgnet.com/2219-2824/full/v3/i3/31.htm |
| DOI |
http://dx.doi.org/10.5411/wji.v3.i3.31 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345